SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2000: cancer incidence, mortality and prevalence worldwide [CD-ROM]. Lyon: International Agency for Research on Cancer, 2000.
  • 2
    Anh PH. Cancer registration in Vietnam. Asian Pacific J Cancer Prev 2001; 2 (IACR Suppl): 8590.
  • 3
    Quoc NM, Hung NC, Parkin DM. Cancer incidence in Ho Chi Minh City, Viet Nam, 1995–1996. Int J Cancer 1998; 76: 4729.
  • 4
    IARC. Monographs on the evaluation of the carcinogenic risks to humans. vol. 64. Human papillomaviruses. Lyon: International Agency for Research on Cancer, 1995.
  • 5
    Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 129.
  • 6
    Coursaget P, Muñoz N. Vaccination against infectious agents associated with human cancer. Cancer Surv 1999; 33: 35581.
  • 7
    Krüger-Kjaer S, van den Brule AJC, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JMM, Meijer CJLM. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomark Prev 1997; 6: 799805.
  • 8
    Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92: 46474.
  • 9
    Lazcano-Ponce E, Herrero R, Muñoz N, Cruz A, Shah KV, Alonso P, Hernandez P, Salmeron J, Hernandez M. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001; 91: 41220.
  • 10
    IARC. Biennial report. Lyon: International Agency for Research on Cancer, 2001. 47.
  • 11
    Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM. A general primer GP5+/GP6 (+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997: 35: 7915.
  • 12
    Jacobs MV, de Roda Husman AM, van den Brule AJC, Snijders PJF, Meijer CJLM, Walboomers JWW. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995; 33: 9015.
  • 13
    Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Dallmeijer N, Meijer CJ. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000; 87: 2217.
  • 14
    Walboomers JWW, Melkert P, van den Brule AJ, Snijders PJF, Meijer CJLM. The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix: In: HerringtonCS, McGeeO, eds. Diagnostic molecular pathology: a practical approach. Oxford: Oxford University Press, 1992. 15272.
  • 15
    Ribes JA, Hayes M, Smith A, Winters JL, Baker DJ. Comparative performance of herpes simplex virus type 2-specific serologic assays from Meridian Diagnostics and MRL diagnostics. J Clin Microbiol 2001; 39: 37402.
  • 16
    Amestoy GM, Matos E, Loria D, Herrera L, Prince MA, Walboomers JMM, Meijer CJLM, Muñoz N, Herrero R, et al. Prevalence of HPV infection in Concordia, Argentina: a population-based study. Proceedings of the 18th International Papillomavirus Conference, Barcelona, 2000, O161, p. 181.
  • 17
    Shin HR, Lee DH, Herrero R, Smith J, Vaccarealla S, Hong SH, Jung KY, Kim HH, Park UD, Cha HS, Park S, Muñoz N, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003; 103: 41321.
  • 18
    Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S, Lorincz A, Dalby DM, Janjusevic V, Keller JL for the Survey of HPV in Ontario Women (SHOW) Group. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Can Med Assoc J 2000; 163: 5038.
  • 19
    Franco EL, Villa LL, Ruiz A, Costa MC. Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. J Infect Dis 1995; 172: 75663.
  • 20
    Muñoz N, Kato I, Bosch FX, Eluf-Neto J, de Sanjosé S, Ascunce N, Gili M, Izarzugaza I, Viladiu P, Tormo MJ, Moreo P, Gonzalez LC, et al. Risk factors for HPV DNA detection in middle-aged women. Sex Trans Dis 1996; 23: 50410.
  • 21
    Hildesheim A, Gravitt P, Schiffman MH, Kurman RJ, Barnes W, Jones S, Tchabo JG, Brinton LA, Copeland C., Epp J, Manos MM. Determinants of genital human papillomavirus infection in low-income women in Washington DC. Sex Trans Dis 1993; 20: 27985.
  • 22
    Bauer HM, Hildesheim A, Schiffman MH, Glass AG, Rush BB, Scott DR, Cadell DM, Kurman RJ, Manos MM. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Trans Dis 1993; 20: 2748.
  • 23
    Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, Peto J. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 2000; 88: 156572.
  • 24
    Muñoz N, Kato I, Bosch FX, Eluf-Neto J, de Sanjosé S, Ascunce N, Gili M, Izarzugaza I, Viladiu P, Tormo M-J, Moreo P, Gonzalez LC, et al. Risk factors for HPV DNA detection in middle-aged women. Sex Trans Dis 1996; 23: 50410.
  • 25
    Mosciki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh T, Palefsky J. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. J Am Med Assoc 2001; 285: 29953002.
  • 26
    Muñoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith J, Shah KV, Meijer CJLM, Bosch FX for the IARC Multicentric Cervical Cancer Study Group. Role of parity and human papillomavirus in cervical cancer: the IARC multi-centric case-control study. Lancet 2002; 359: 1093101.
  • 27
    Moreno V, Bosch FX, Muñoz N, Meijer CJLM, Shah KV, Walboomers JMM, Herrero R, Franceschi S for the IARC Multicentric Cervical Cancer Study Group. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multi-centric case-control study. Lancet 2002; 359: 108592.
  • 28
    Castellsagué X, Menéndez C, Loscertales MP, Kornegay JR, dos Santos F, Gómez-Olivé FX, Lloveras B, Abarca N, Vaz N, Barreto A, Bosch FX, Alonso P. Human papillomavirus genotypes in rural Mozambique. Lancet 2002; 358: 142930.
  • 29
    Woodman CBJ, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001; 357: 18316.
  • 30
    Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; (in press).